Literature DB >> 11361181

Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura.

M M Amoli1, D L Mattey, M C Calviño, C Garcia-Porrua, W Thomson, A H Hajeer, W E Ollier, M A Gonzalez-Gay.   

Abstract

OBJECTIVE: Henoch-Schonlein purpura (HSP) is a small sized vasculitis affecting mainly children. Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms have recently been implicated in the susceptibility to some vasculitides. To further investigate the clinical implication of ICAM-1 polymorphisms in HSP, we examined their potential association and influence in the development of severe complications in an unselected series of patients with HSP.
METHODS: Fifty-two patients, of which 41 were children, were diagnosed with HSP using classification criteria of Michel, et al at the Hospital Xeral-Calde (Lugo, Spain); 129 ethnically matched controls were included. Patients had at least one year of followup. Patients and controls were genotyped by allelic oligonucleotide techniques for ICAM-I polymorphism at codon 241 and 469.
RESULTS: The frequency distribution of the alleles and genotypes for each ICAM-1 polymorphism did not show significant differences between HSP patients and controls. Also, no differences between patients with or without renal manifestations were found. However, the frequency of the codon 469 K/E genotype was significantly decreased in patients without severe gastrointestinal manifestations compared to those with them (22.29 vs 65%, OR 0.1, p = 0.02, after correction for age, sex, and disease duration). None of the 11 adults exhibited the R/G genotype at codon 241 compared with 7 of 41 children (OR 0.0, 95% CI 0.0-2.9, p = 0.14). Patients with the R/G genotype were associated with low incidence of renal manifestations and none developed permanent renal involvement (renal sequelae); however, this finding did not achieve statistical significance.
CONCLUSION: ICAM-1 polymorphisms alone are not associated with development of HSP, but patients not carrying the codon 469 K/E genotype are at decreased risk of developing severe gastrointestinal complications. The R/G polymorphism at codon 241 may reduce the risk of renal sequelae in the development of HSP in adulthood.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11361181

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Henoch-Schönlein purpura complicated with severe gastrointestinal bleeding.

Authors:  Tomoyuki Yamazaki; Tetsu Akimoto; Yoshitaka Iwazu; Taro Sugase; Eri Takeshima; Akihiko Numata; Takanori Komada; Hiromichi Yoshizawa; Naoko Otani; Yoshiyuki Morishita; Osamu Saito; Fumi Takemoto; Shigeaki Muto; Eiji Kusano; Daisuke Nagata
Journal:  CEN Case Rep       Date:  2014-10-02

2.  G241R and K469E polymorphisms of intercellular adhesion molecule 1 (ICAM-1) could predispose to Hashimoto thyroiditis.

Authors:  Fevziye Emin Akman; Müge Kanmaz-Özer; Pervin Vural; Ayşenur Özderya; Berrin Karadağ; Semra Doğru-Abbasoğlu; Müjdat Uysal
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

3.  Gastrointestinal issues in children with rheumatologic disease.

Authors:  Mirna Chehade; Keith Benkov
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

4.  Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with Henoch-Schönlein purpura.

Authors:  Yilmaz Tabel; Sevgi Mir; Afig Berdeli
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 2.631

Review 5.  The genetics of Henoch-Schönlein purpura: a systematic review and meta-analysis.

Authors:  Xuelian He; Chunhua Yu; Peiwei Zhao; Yan Ding; Xiaohui Liang; Yulan Zhao; Xin Yue; Yanxiang Wu; Wei Yin
Journal:  Rheumatol Int       Date:  2013-01-17       Impact factor: 2.631

6.  Association of TLR4 gene polymorphisms with childhood Henoch-Schönlein purpura in a Chinese population.

Authors:  Hui Xu; Guizhen Jiang; Hongqiang Shen; Wei Li; Jianhua Mao; Yanxiang Pan
Journal:  Rheumatol Int       Date:  2017-09-13       Impact factor: 2.631

7.  Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease.

Authors:  Beata Sarecka-Hujar; Iwona Zak; Jolanta Krauze
Journal:  Clin Exp Med       Date:  2008-12-02       Impact factor: 3.984

8.  ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas.

Authors:  Regislaine Valéria Burim; Silvia Aparecida Teixeira; Benedicto Oscar Colli; Fernanda Maris Peria; Luis Fernando Tirapelli; Suely Kazue Nagahashi Marie; Suzana Maria Fleury Malheiros; Sueli Mieko Oba-Shinjo; Alberto Alain Gabbai; Paulo Andrade Lotufo; Carlos Gilberto Carlotti-Júnior
Journal:  Clin Exp Med       Date:  2009-03-21       Impact factor: 3.984

9.  BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis.

Authors:  Diana Prieto-Peña; Fernanda Genre; Sara Remuzgo-Martínez; Verónica Pulito-Cueto; Belén Atienza-Mateo; Javier Llorca; Belén Sevilla-Pérez; Norberto Ortego-Centeno; Leticia Lera-Gómez; María Teresa Leonardo; Ana Peñalba; Javier Narváez; Luis Martín-Penagos; Emilio Rodrigo; José A Miranda-Filloy; Luis Caminal-Montero; Paz Collado; Javier Sánchez Pérez; Diego de Argila; Esteban Rubio; Manuel León Luque; Juan María Blanco-Madrigal; Eva Galíndez-Agirregoikoa; Oreste Gualillo; Javier Martín; Santos Castañeda; Ricardo Blanco; Miguel A González-Gay; Raquel López-Mejías
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

10.  Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis.

Authors:  Mario Sestan; Nastasia Kifer; Marijan Frkovic; Matej Sapina; Sasa Srsen; Mateja Batnozic Varga; Aleksandar Ovuka; Martina Held; Ana Gudelj Gracanin; Ana Kozmar; Stela Bulimbasic; Marijana Coric; Gordana Laskarin; Alenka Gagro; Marija Jelusic
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-30       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.